Premium Nahrungsergänzungsmittel | artgerecht

Endocan – Biomarker for Vascular Inflammation

Endocan is a biomarker produced by endothelial cells that indicates inflammatory processes and vascular diseases. It is used in research and diagnostics.

Regular tips about health Regular tips about health

Things worth knowing about "Endocan"

Endocan is a biomarker produced by endothelial cells that indicates inflammatory processes and vascular diseases. It is used in research and diagnostics.

What is Endocan?

Endocan, also known as ESM-1 (Endothelial Cell-Specific Molecule 1), is a soluble proteoglycan primarily produced and secreted into the bloodstream by endothelial cells – the cells lining the inner walls of blood vessels. First identified in the 1990s, it is recognized as an important biomarker for vascular inflammation and endothelial dysfunction.

The molecule consists of a protein core linked to a single dermatan sulfate glycosaminoglycan chain. This structure enables Endocan to interact with various cytokines and growth factors, thereby modulating inflammatory processes.

Biological Function

Endocan plays a central role in regulating inflammatory responses within the vascular system. Its key biological functions include:

Modulation of leukocyte migration: Endocan inhibits the movement of white blood cells (leukocytes) into inflamed tissue by influencing leukocyte adhesion to the endothelium.
Interaction with cytokines: It binds to pro-inflammatory cytokines such as TNF-α (Tumor Necrosis Factor Alpha) and modulates their activity.
Angiogenesis: Endocan is involved in the formation of new blood vessels, a process relevant to wound healing as well as tumor growth.
Endothelial homeostasis: It contributes to maintaining the normal function of the vascular endothelium.

Endocan as a Biomarker

In clinical research and medicine, Endocan is used as a serum biomarker, as its concentration in the blood is significantly altered in various diseases. Elevated Endocan levels have been observed in the following conditions:

Sepsis and Septic Shock: Endocan is considered a sensitive marker for the severity of sepsis and can help monitor disease progression.
Cardiovascular Diseases: Elevated levels are found in coronary artery disease, arterial hypertension, and atherosclerosis.
Kidney Diseases: Altered Endocan levels are detectable in chronic kidney disease and renal failure.
Malignant Tumors: In various cancers, particularly lung and kidney cancer, Endocan is overexpressed and correlates with tumor aggressiveness and prognosis.
Inflammatory Conditions: Elevated values are measurable in systemic inflammatory responses, autoimmune diseases, and infectious diseases.

Diagnostic Significance

Endocan is typically measured using an ELISA (Enzyme-Linked Immunosorbent Assay) from a blood sample. Normal serum concentrations in healthy adults range from approximately 0.3 to 3 ng/ml, although values may vary depending on the assay used.

As a diagnostic tool, Endocan offers several advantages:

It directly reflects the condition of the vascular endothelium.
It can indicate inflammatory processes at an early stage, before other clinical signs become apparent.
It allows monitoring of disease progression in chronic conditions.

However, Endocan as a clinical biomarker is still partly in the research phase. Standardized reference values and testing procedures are being further developed before widespread routine clinical application becomes possible.

Therapeutic Potential

Due to its central role in inflammatory and vascular processes, Endocan is also being investigated as a potential therapeutic target molecule. Approaches aimed at inhibiting or modulating Endocan could in the future be relevant for the treatment of sepsis, cardiovascular diseases, or certain cancers. However, this research is still in the experimental stage.

References

Lassalle, P. et al. (1996): ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. Journal of Biological Chemistry, 271(34), 20458–20464.
Mihajlovic, D. et al. (2014): Endocan – from basic research to clinical practice. Inflammation Research, 63(12), 933–942.
Sarrazin, S. et al. (2010): Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel pan-endothelial marker. Progress in Histochemistry and Cytochemistry, 45(3), 165–200.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.